FDA Issues 2 Guidances On Drug Compounding
The U.S. Food and Drug Administration on Tuesday issued two guidances to clarify good manufacturing practices and enforcement regulations for drug compounding as it boosts its oversight over the controversial practices....To view the full article, register now.
Already a subscriber? Click here to view full article